Papers And Originals

Luteinizing Hormone and Follicle Stimulating Hormone-Releasing Hormone Test in Patients with Hypothalamic Pituitary-Gonadal Dysfunction

Br Med J 1973; 4 doi: https://doi.org/10.1136/bmj.4.5884.73 (Published 13 October 1973) Cite this as: Br Med J 1973;4:73
  1. C. H. Mortimer,
  2. G. M. Besser,
  3. A. S. McNeilly,
  4. J. C. Marshall,
  5. P. Harsoulis,
  6. W. M. G. Tunbridge,
  7. A. Gomez-Pan,
  8. R. Hall

    Abstract

    A standard intravenous 100 μg luteinizing hormone/follicle stimulating hormone-releasing hormone (LH/FSH-RH) test was used to assess the pituitary gonadotrophin responses in 155 patients with a variety of diseases of the hypothalamic-pituitary-gonadal axis. In all but nine patients there was an increase in circulating levels of either LH or FSH in response to the releasing hormone though 137 (88%) were clinically hypogonadal. It was not possible with this test to distinguish between hypothalamic and pituitary causes of hypogonadotrophic hypogonadism, since a variety of LH and FSH responses emerged within the disease groups. However, primary gonadal failure characteristically resulted in exaggerated gonadotrophin response. The potential therapeutic use of the gonadotrophin releasing decapeptide is suggested in certain patients with hypogonadotrophic hypogonadism.